⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16358955 | 0.66 | — | — | |
| SCHEMBL19418158 | 0.65 | — | — | |
| SCHEMBL14997321 | 0.63 | — | — | |
| SCHEMBL18790367 | 0.63 | — | — | |
| SCHEMBL15255867 | 0.63 | — | — | |
| SCHEMBL15918681 | 0.63 | — | — | |
| SCHEMBL19417900 | 0.62 | — | — | |
| SCHEMBL15458222 | 0.60 | — | — | |
| SCHEMBL19418373 | 0.58 | — | — | |
| SCHEMBL19418165 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2925757-B1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | NOVARTIS AG (CH) | 2017-10-04 | — | — | EP | disclosed |